PINXF vs BAC: Which Stock is Better?
Side-by-side comparison of The People's Insurance Company (Group) of China Limited and Bank Of America Corp in 2026
PINXF
The People's Insurance Company (Group) of China Limited
$0.75
BAC
Bank Of America Corp
$53.91
Key Metrics Comparison
| Metric | PINXF | BAC | Winner |
|---|---|---|---|
| Market Cap | $43.78B | $382.37B | BAC |
| P/E Ratio | 5.02 | 13.31 | PINXF |
| EPS (TTM) | $0.15 | $4.02 | BAC |
| Revenue Growth | -0.0% | 0.1% | BAC |
| Gross Margin | 14.6% | 100.0% | BAC |
Analyze PINXF
Full quant analysis
Analyze BAC
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PINXF or BAC a better investment?
Comparing PINXF and BAC: The People's Insurance Company (Group) of China Limited has a market cap of $43.78B while Bank Of America Corp has $382.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PINXF and BAC?
PINXF (The People's Insurance Company (Group) of China Limited) and BAC (Bank Of America Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PINXF or BAC?
Based on P/E ratios, PINXF trades at a lower multiple (5.0x vs 13.3x).
Which is growing faster: PINXF or BAC?
BAC has higher revenue growth at 0.1% vs -0.0% for PINXF.
Which company is more profitable: PINXF or BAC?
Bank Of America Corp (BAC) has higher gross margins at 100.0% compared to 14.6% for PINXF.
Which is the larger company: PINXF or BAC?
Bank Of America Corp (BAC) is larger with a market cap of $382.37B compared to $43.78B for PINXF.
Should I buy PINXF or BAC in 2026?
Both PINXF and BAC have investment merit. PINXF trades at $0.75 while BAC trades at $53.91. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PINXF and BAC stock?
Key differences: Market Cap ($43.78B vs $382.37B), P/E Ratio (5.0x vs 13.3x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (14.6% vs 100.0%).